DalsnaFinance › IPOs › Diamedica Therapeutics Inc › IPO

DiaMedica Therapeutics Inc. IPO

Completed

DiaMedica Therapeutics Inc. completed its initial public offering on NASDAQ on December 7, 2018, pricing at $4.00 a share.

Ticker	DMAC
Exchange	NASDAQ
Status	Completed
Listing date	December 7, 2018
Offering price	$4.00
Shares offered	4,100,000
Total raised	$16M

The offering

DiaMedica Therapeutics Inc. sold 4,100,000 shares at $4.00 each on NASDAQ. Multiplied out, that is $16.4 million in gross proceeds, the figure before underwriting discounts and offering expenses, and it agrees with the $16 million total recorded for the deal.

Company coverage

DiaMedica Therapeutics Inc. — quote, profile and latest news →

Other recent IPOs

Iambic Therapeutics, Inc. · October 13, 2026
Retension Pharmaceuticals, Inc. · October 8, 2026
Frazier Life Sciences Acquisition Corp. II · October 8, 2026
TRex Bio, Inc. · October 6, 2026
Pine Tree Acquisition Corp. · October 5, 2026
Accelevation Holdings Corp. · September 30, 2026
Southport Acquisition Corp. II · September 30, 2026
ROZE AI INC. · September 28, 2026

Source: SEC EDGAR filings for DiaMedica Therapeutics Inc.. This page is general information, not investment advice.